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Background: Thoroughbred horses are the most expensive domestic animals, and their running ability and
knowledge about their muscle-related diseases are important in animal genetics. While the horse reference
genome is available, there has been no large-scale functional annotation of the genome using expressed genes
derived from transcriptomes.
Results: We present a large-scale analysis of whole transcriptome data. We sequenced the whole mRNA from the
blood and muscle tissues of six thoroughbred horses before and after exercise. By comparing current genome
annotations, we identified 32,361 unigene clusters spanning 51.83 Mb that contained 11,933 (36.87%) annotated
genes. More than 60% (20,428) of the unigene clusters did not match any current equine gene model. We also
identified 189,973 single nucleotide variations (SNVs) from the sequences aligned against the horse reference
genome. Most SNVs (171,558 SNVs; 90.31%) were novel when compared with over 1.1 million equine SNPs from
two SNP databases. Using differential expression analysis, we further identified a number of exercise-regulated
genes: 62 up-regulated and 80 down-regulated genes in the blood, and 878 up-regulated and 285 down-regulated
genes in the muscle. Six of 28 previously-known exercise-related genes were over-expressed in the muscle after
exercise. Among the differentially expressed genes, there were 91 transcription factor-encoding genes, which
included 56 functionally unknown transcription factor candidates that are probably associated with an early
regulatory exercise mechanism. In addition, we found interesting RNA expression patterns where different
alternative splicing forms of the same gene showed reversed expressions before and after exercising.
Conclusion: The first sequencing-based horse transcriptome data, extensive analyses results, deferentially expressed
genes before and after exercise, and candidate genes that are related to the exercise are provided in this study.
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The thoroughbred, a “hot-blooded” horse breed, is
the favorite breed for use in horse racing [1]. The
speed and agility of thoroughbred horses has
resulted in the emergence of an industry involved in
the breeding, training, and racing of elite racehorses
worth many billions of dollars [2]. Until now, rela-
tively few genes related to their athletic phenotypes
have been identified, even though physical and
physiological adaptations underlying their elite ath-
leticism are well characterized [3]. Muscle is the
most critical tissue for athletic performance. The
skeletal muscle of the thoroughbred horse comprises
over 55% of its total body mass [4,5] and has re-
markable functional and structural plasticity [3]. Fur-
thermore, over 90 hereditary conditions in horses
have corresponding human disorders [3,6], and many
muscle disorders in humans and horses share com-
mon clinical and histopathological characteristics, as
well as molecular features [7-9]. Therefore, the horse
can be an invaluable animal model for muscle
diseases.
An international team of researchers has decoded
the genome of the domestic horse, Equus caballus,
and has reported that its genome structure is re-
markably similar to the human genome [8]. An add-
itional nine domesticated horse breeds have also
been sequenced, identifying around one million sin-
gle nucleotide polymorphisms (SNPs) [8]. However,
there has been little progress in refining the func-
tional annotation of horse genome using expressed
genes. Although a small number (around 30,000) of
expressed sequence tags (ESTs) has been deposited
in the dbEST [10], this is insufficient to identify all
the key genes related to specific functions, such as
racing performance.
RNA-Seq is one of the most useful next generation se-
quencing (NGS) methods used to fully understand the
landscape of a transcriptome, because it produces sev-
eral tens of millions of short reads (17 bp to 101 bp)
from the expressed genes in vivo. RNA-Seq has been
used successfully to investigate the transcriptome pro-
files of human, mouse, Arabidopsis, and yeast [11-14].
The RNA-Seq data generally exhibit a high degree of
concordance with established gene annotations [15,16].
Using RNA-Seq, researchers have identified numerous
novel genes and additional alternative splicing forms
[14,17,18], as well as unraveling expression profiles
underlying phenotypic changes, such as development
stages [19,20]. In addition, RNA-Seq permits the identifi-
cation of single nucleotide variations (SNVs) in coding
regions from various organisms because of the large
number of reads [14,21,22]. Moreover, RNA-Seq has
identified novel unannotated transcriptionally activeregions in rice [23], indicating that there are novel genes
that cannot be detected by conventional gene prediction
methods.
In horses, two transcriptome studies using RNA-
Seq have been reported: one study refined the struc-
tural annotation of protein-coding genes based on
the RNA-Seq sequences from several equine tissues
[24], while the other analyzed RNA-Seq sequences
acquired from skeletal muscle to find long-term
training-related genes [25]. Both studies used very
short RNA-Seq sequences, 17 bp and 35 bp, respect-
ively, because of the limitation of NGS technologies
available at that time. These very short-read RNA
sequences have one critical limitation. When aligned
against the reference genome, the typical success
rate is as low as 66% in the case of 17 bp RNA frag-
ments [24]. This was caused not only by the very
short-read sequences, but also by intron junctions,
which were not included in the short-reads. This
disadvantage must be overcome to advance horse
transcriptome research.
Here, we present a large scale analysis of whole tran-
scriptome data. The samples were taken from blood and
muscle tissues of six thoroughbred horses before and
after 30 minutes of exercises, resulting in 24 samples.
Results and discussion
Gene cluster analysis and identification of novel
transcripts from the horse RNA-Seq sequences
To construct high quality horse transcriptome data, we
generated over 1.3 billion 90-bp pair-end reads using an
Illumina HiSeq2000 (Additional file 1: Figure S1,
Additional file 1: Table S1, and Table S2). Using TopHat
[26] and Cufflinks [27], 84.60% of all the reads were
successfully mapped against the current horse reference
genome (Additional file 1: Table S3). A novel bioinfor-
matics protocol for processing large amounts of tran-
scriptome sequences was built (Additional file 1: Figure
S2). RNA sequences were obtained from 24 different
samples; therefore, we defined a new concept, unigene
cluster (UC), which contains overlapped unigene
sequences originating from multiple samples. Utilizing
the current annotation (Ensembl 62), 32,361 unigene
clusters (UCs), with a total length of 51.83 Mb, were
identified. 11,933 UCs matched current gene models,
which comprised 36.87% of the 32,361 UCs (Figure 1A
and Additional file 1: Supplementary Methods) [8]. The
remaining 20,428 UCs (63.13%), which contained more
than 60% of the transcripts, were novel (Additional file 1:
Supplementary Methods and Additional file 1: Figure S3).
The expressions of eight randomly selected novel UCs
were confirmed by reverse transcription PCR (Additional
file 1: Figure S4 and Additional file 1: Table S4). In
addition, the unmapped raw sequences were processed by
Figure 1 Enhanced genome annotation, single nucleotide variation analyses, and differentially expressed genes before and after
exercise in horse. (A) Red and green circles indicate expressed genes in the blood and muscle tissues, respectively, and the blue circle shows
the current Ensembl annotation (Release 62). The grey rectangle indicates the coverage of the current horse genome. (B) Green circle: SNPs
provided by the Broad Institute, red circle: SNPs provided by Ensembl (release 62), blue circle: SNPs identified from this study. (C) SNV profiles of
six horses for the titin (TTN) gene. The top of the blue arrow is the 5' end and the bottom is 3' end of TTN gene. The X-axis shows the names of
the horses. Dark green horizontal bars are non-synonymous SNVs. Light green horizontal bars are synonymous SNVs. (D) Blue bars: >2-fold
upregulated genes, red bars: >2-fold downregulated genes, white bars: not differentially expressed. The four pie charts display the composition of
the DEGs supported by four horses (white), five horses (light grey), and six horses (grey).
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72,011 scaffolds for each sample. These assembled
sequences increased the extent of the current horse
genome (Additional file 1: Supplementary Methods,
Additional file 1: Figure S2, and Additional file 1: Tables
S5, S6, S7, S8). When we pooled the scaffolds together,
we identified around 670,000 non-redundant unigenes.
27% to 46% of these unigenes from each sample werematched to human genes using tBLASTx (Additional file
1: Table S9).
Identification and dissection of novel SNVs from a large
amount of horse RNA-Seq sequences
We identified 182,722 non-redundant SNPs and 7,251
non-redundant INDELs from the 24 samples using several
filters, including an exon-intron boundary misalignment
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S10, S11, S12, and Additional file 1: Supplementary
Methods). The filters had been validated on mouse
RNA-Seq data [29] by showing that 80.28% of the identi-
fied SNPs were confirmed in two inbred mouse genomes
(Additional file 1: Supplementary Methods and Additional
file 1: Table S13). Each horse showed a similar number of
SNVs, ranging from 72,000 to 77,000 (Additional file 1:
Table S11). 82,476 individual-specific SNVs were identified
(Additional file 1: Table S12). Only 7,316 out of 182,722
SNPs (4.00%) overlapped with both of the two existing data-
bases (Figure 1B). This is because only 1% (10,229 from
Broad Institute and 4,287 from Ensembl) of the SNPs from
the two databases were located in the exonic region of the
current genome annotation (Additional file 1: Tables S11
and S14). These results demonstrate the usefulness of iden-
tifying novel SNPs from transcriptome data. Moreover,
116,650 (61.40%) of 189,973 SNVs were located in exons of
unigene clusters, and 67,788 (58.11%) of the 116,650 SNVs
caused amino acid changes. Some of the transcripts are pos-
sibly related to the horses’ running ability. For example, titin
(TTN) is related to the passive stiffness of muscle by limiting
the range of motion of the sarcomere in tension [30], such
that TTN affects the ability of muscle directly [31]. Other
examples include obscurin (OBSCN), which is associated
with TTN and ANK1 genes [32,33], and the skeletal muscle
calcium release channel gene (RYR1) located in the sarco-
plasmic reticulum [34,35], whose mutations caused several
muscle-related diseases, including central core disease [36].
The SNV distribution profile of the TTN was specific to in-
dividual horses (Figure 1C and Additional file 1: Table S15).
Comparison of the expressed genes in blood and muscle
tissues with other organisms
In muscle and blood tissues, 17,484 and 25,220 UCs
were identified as expressed genes, respectively,
showing that blood expressed about 40% more genes
than muscle tissue (Figure 1A). By comparison with
two previous RNA-Seq studies conducted in human
(Illumina BodyMap2 transcriptome) and in mouse
skeletal muscle tissue [12], we observed that the GO
classifications of all the expressed genes in the three
organisms were similar to each other (Additional file
1: Figure S6). The differences in GO assignments be-
tween tissues (muscle and blood) were larger than
those of the same tissue among the three species
(Additional file 1: Figure S7).
Identification and characterization of differentially
expressed genes in blood and muscle tissues regulated
by exercise
We calculated the expression level of all unigenes from
the 24 samples. The distribution of 32,361 UCs’ average
expression levels in the 24 samples showed that half ofthe UCs were expressed at less than 0.19 FPKM (frag-
ments per kilobase of exon model per million mapped
reads) and three-quarters of the UCs were expressed at
less than 4.81 FPKM (Additional file 1: Figure S10). The
correlation coefficients of the FPKM values among the
samples were comparable to previous RNA-Seq studies
[15,37] (Additional file 1: Figures S8 and S9). By compar-
ing before and after 30 minutes of exercise, we identified
1,285 differentially expressed genes (DEGs), consisting
of 62 up- and 80 downregulated UCs in blood and 878
up- and 285 downregulated UCs in muscle (Additional
file 1: Supplementary Methods and Figure 1D). While
the overall number of all the differentially expressed UCs
was much larger in muscle than in blood, the number of
novel differentially expressed UCs was larger in blood (42
UCs) than in muscle (8 UCs) (Additional file 1: Table
S16).
We examined 28 genes that are known to be asso-
ciated with racing performance in horses [38].
Twelve of the 25 genes successfully mapped on the
genome annotation were expressed in muscle and
blood, and six were differentially expressed in muscle
(Additional file 1: Table S17). The rest were detected
in neither of the two tissues. The six genes upregu-
lated by exercise were: HIF1A, which encodes a tran-
scription factor that responds to hypoxia; ADRB2,
which is involved in the regulation of energy ex-
penditure and lipid mobilization from adipose;
PPARD, which regulates expression of genes involved
in lipid and carbohydrate metabolisms; VEGF, which
is an important angiogenic factor recovering the oxy-
gen supply to tissues when blood vessels are blocked;
TNC, which is located in positive-selected regions
for racing performance [4]; and BDNF, which is a
candidate gene that may be associated with exercise
behavior [39].
We also compared differentially expressed genes
(DEGs) in muscle tissue with the 15 upregulated and
53 downregulated DEGs that are associated with ex-
ercise training [25] (Additional file 1: Table S18).
Among these 68 DEGs, only five genes, ACTR3B,
FBXO32, PER3, C1orf51, and GATM, were identified
as DEGs in this study, among which C1orf51 and
PER3 showed a different expression profile.
Sampling the transcriptomes immediately after ex-
ercise enabled the identification of differentially
expressed early response genes that are rapidly
induced by exercise. Many early response proteins
include transcriptional regulators, such as Mitogen-
activated protein kinases (MAPKs) and NF-κB, which
promote fuel homeostasis and prevent skeletal
muscle atrophy [40]. In addition, important oxidative
stress-sensitive enzymes that can be activated by NF-
κB and MAPKs after exercise, such as inducible nitric
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were upregulated in horse muscle after exercise.
Among the 1,285 DEGs from the two tissues, we iden-
tified 91 transcription factors, which might regulate
downstream components of exercise-triggered signal-
ing pathways (Additional file 1: Table S19). GATA2,
which can interact with AP1 transcription factors to
regulate MAPK and NF-κB signaling [42], was under-
expressed in blood, while CREB5, whose zinc-finger
and bZIP domain can specifically bind to the CRE with
c-Jun or CRE-BP1 [43], was overexpressed in muscle.
Upregulation of CREB5 might be explained by the fact
that CREB5 and c-Jun genes are involved in calcium-
dependent transcriptional pathways in skeletal muscle
[44].
At least 56 uncharacterized transcription factors could
be candidates for novel primary transcriptional regula-
tors accompanying exercise. We validated the expression
levels of seven randomly chosen transcription factors
using quantitative RT-PCR from the remaining sample
materials (Additional file 1: Tables S20 and S21).Figure 2 Switching expressions of alternatively spliced forms before
of the DYNC1 gene: ENSECAT00000021919 and ENSECAT00000021863. (B) E
kilobase of exon per million fragments mapped) of the two transcripts (Blu
represent the ENSECAT00000021863 transcript) in each individual horse, wh
the coverages of the transcripts.Switching the expression pattern of alternative splicing
forms of the gene before and after exercising
Four genes (three from muscle, one from blood) showed
interesting RNA expression patterns, in which two dif-
ferent alternative splicing forms of the same gene
showed reversed expression patterns before and after ex-
ercising, similar to that of the SXL gene in Drosophila
[45]. This observation suggested a cost-effective method
of regulation: the cells do not have to produce com-
pletely new exons and proteins, but merely change the
composition of the existing exons [46]. The genes with
reversed expression are: AXL, DYNC1, PLEKHG1, and
COBLL1 (Additional file 1: Table S22 and Additional file
1: Figure S11). Figure 2 shows cytoplasmic dynein inter-
mediate chain (ENSECAG00000020218) protein
(DYNC1) [47] as an example of the reversed expression
pattern in muscle before and after exercising.
Conclusion
We generated a large amount of horse transcriptome
data. Their analyses provided candidate genes that areand after exercise. (A) Red bars are the exons of the two transcripts
ach plot shows the gene expression level (FPKM value; fragments per
e lines represent the ENSECAT00000021919 transcript and red lines
ose name is shown as the plot title. Percentages inside the plots are
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tified exercise-associated genes and 91 early regulated
transcription factors that are differentially expressed by
exercise, three genes that display high SNV density, and
four alternatively expressed splicing variants. In addition,
all 1,258 differentially expressed genes could be import-
ant candidate genes for further research.
Methods
The muscle and blood samples from six retired
thoroughbred horses were taken before and after
trotting (30 minutes). 90-bp pair-end sequences were
obtained with an Illumina HiSeq2000, San Diego,
US, from the samples. These sequences were mapped
against the horse reference genome (Ensembl release
62) using TopHat 1.2.0 with two options (−−mate-
inner-dist = 200 and –allow-indels) for paired-end
sequences and identified unigenes using the Cuf-
flinks program without genome annotation data.
From the results of 24 samples, novel genes were
clustered based on the genomic coordination to de-
fine unigene clusters (UCs). The generated UCs were
subjected to the filter, which extracted UCs overlap-
ping with the genome annotation. The expressed
genes annotated by the pipeline and the filtered UCs
were merged as the final set of UCs. In addition,
unmapped sequences were assembled by the SOAP-
denovo [28] program and were subjected to an ORF
length filtering process. In-house bioinformatics
pipelines were used to identify SNVs under several
stringent conditions, especially for the exon-intron
boundary misalignment filter (See Additional file 1:
Supplementary Methods). Differentially expressed
genes were selected by comparing the expression
profiles of the six horses, with a selection criterion
of more than two fold up- or downregulation in four
or more horses.Data access
All raw sequences of the horse transcriptomes are open-
freely available at http://www.horsegenome.net/.
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Additional file 1: Figure S1. Six thoroughbred horses. Table S1. 24
sample names from six thoroughbred horses used in this study. Table
S2. The statistics of RNA-Seq raw data from 24 different samples. Table
S3. The mapping results against the horse reference genome (Ensembl
62). Figure S2. Procedure for identifying horse unigenes. Figure S3.
Distribution plot of the exons identified without gene models which
contain ORFs. Figure S4. Reverse transcript PCR (RT-PCR) confirmation of
the 8 novel unigene clusters (UCs) Table S4. Primer information for the
RT-PCR experiment. Table S5. Statistics of the filtered de novo transcripts
identified from cufflink. Table S6. de novo assembly results from one
sample with various k-mer values. Table S7. de novo assembly of
unmapped sequences originated from 24 samples. Table S8. Filteredand clustered unigenes from the scaffolds assembled from unmatched
sequences. Figure S5. The whole process of identifying SNVs. Table S9.
The proportion of the scaffolds from the unmapped sequences which
were matched against the human genome. Table S10. The statistics of
total SNVs identified from 24 samples. Table S11. The number of total
SNVs identified in thoroughbred horses. Table S12. The number of
individual-specific SNVs. Table S13. Conformation of the SNPs identified
from the mouse sample [2]. Table S14. Distribution of SNP locations in
three datasets. Table S15. The list of transcripts which have ten or more
non-synonymous SNPs. Figure S6. GO classification of all expressed
genes in human, mouse, and horse muscle tissue. Figure S7. GO
classification of all expressed horse genes in blood and muscle tissue.
Figure S8. Correlation matrix of the 24 samples. Figure S9. Correlation
matrix of three human samples from kidney and liver tissues. Figure S10.
Histogram of average expression level of the unigene clusters in the 24
samples. Table S16. List of DEGs in muscle and blood tissues. Table S17.
Expression profiles of known exercise-related horse genes. Table S18.
Comparison between DEGs in muscle tissue and the DEGs which are
responsible to exercise training [25]. Table S19. List of transcription
factors differentially expressed in muscle and blood tissues. Table S20.
RT-PCR primers for seven transcription factors. Table S21. RT-PCR results
of differentially expressed transcription factors in muscle tissue. Table
S22. The list of four genes of which alternative splicing forms showed
reversed expression patterns before and after exercising. Figure S11.
Expression profiles of the genes of which alternative splicing forms
showed reversed expression patterns before and after exercising. Table
S23. Number of filtered de novo transcripts identified by Cufflink.
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